Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,025.60
-27.00 (-1.32%)
Aug 6, 2025, 3:29 PM IST
Glenmark Pharmaceuticals Employees
Glenmark Pharmaceuticals had 14,989 employees as of March 31, 2024. The number of employees decreased by 567 or -3.64% compared to the previous year.
Employees
14,989
Change (1Y)
-567
Growth (1Y)
-3.64%
Revenue / Employee
$8,963,548
Profits / Employee
$698,577
Market Cap
571.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 14,989 | -567 | -3.64% |
| Mar 31, 2023 | 15,556 | 141 | 0.91% |
| Mar 31, 2022 | 15,415 | 4,451 | 40.60% |
| Mar 31, 2021 | 10,964 | 297 | 2.78% |
| Mar 31, 2020 | 10,667 | -3,333 | -23.81% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Mankind Pharma | 26,978 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Aurobindo Pharma | 26,015 |
Glenmark Pharmaceuticals News
- 20 days ago - Nomura remains neutral on Glenmark, says near-term upside for stock captured post ISB-2001 deal - Business Upturn
- 23 days ago - Top stocks to buy: Stock recommendations for the week starting July 14, 2025 - check list - The Times of India
- 23 days ago - Top stocks in focus on July 14; DMart, Glenmark Pharma, VIP Industries, NCC, RITES, Ajmera Realty and more - Business Upturn
- 23 days ago - HSBC raises Glenmark Pharma share price target to Rs 2,275 on $1.9 billion AbbVie licensing deal - Business Upturn
- 25 days ago - Glenmark Pharma receives warning letter from US FDA for Indore facility - Business Upturn
- 26 days ago - Glenmark Pharma shares surge 10% after its subsidiary signs $700 million licensing deal with AbbVie for ISB 2001 - Business Upturn
- 26 days ago - Top stocks in focus on July 11: Tata Steel, TCS, Tata Elxsi, Glenmark Pharma, HUL, JSW Infrastructure and more - Business Upturn
- 27 days ago - Glenmark shares in focus after $700 million AbbVie deal for ISB 2001 - Business Upturn